Neurona is a biotherapeutics company developing neural cell therapies with single-dose curative potential for the treatment of chronic neurological disorders. Based on a novel neural cell lineage pioneered by the company’s scientific founders, Neurona has built a robust regenerative platform and is developing neuronal, glial, and gene-edited cell therapy candidates that provide long-term repair of dysfunctional neural networks for multiple neurological disorders. For more information about Neurona visit our website.
Location: United States, California, South San Francisco
Employees: 51-200
Total raised: $294.6M
Founded date: 2008
Investors 5
| Date | Name | Website |
| - | Berkeley F... | berkeleyfr... |
| - | UCB Ventur... | ucbventure... |
| - | The Column... | thecolumng... |
| 08.03.2024 | Ysios Capi... | ysioscapit... |
| - | SymBiosis | symbiosis.... |
Funding Rounds 5
| Date | Series | Amount | Investors |
| 03.04.2025 | - | $102M | - |
| 09.02.2024 | - | $120M | - |
| 22.06.2021 | - | $41.5M | - |
| 01.12.2015 | Series A | $23.5M | UCB Ventur... |
| 24.12.2014 | - | $7.6M | - |
Mentions in press and media 24
| Date | Title | Description |
| 03.04.2025 | Neurona Therapeutics Raises $102 Million to Fuel NRTX-1001 Phase 3 EPIC Epilepsy Trial and Advance Regenerative Cell Therapy Pipeline | South San Francisco, CA, April 3, 2025 – Neurona Therapeutics, a clinical-stage, privately-held, biotherapeutics company developing regenerative cell therapies for disorders of the nervous system, today announced the successful completion o... |
| 06.12.2024 | Neurona Therapeutics Presents Positive Clinical Update: New Data from NRTX-1001 Cell Therapy Trial in Drug-resistant Epilepsy Announced at 2024 Annual Meeting of the American Epilepsy Society | San Francisco, CA, December 6, 2024 – Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for epilepsy and other disorders of the nervous system, today announced positive clinical data from t... |
| 10.09.2024 | Neurona Therapeutics Receives $3.8 Million CIRM Grant for the Development of Next Generation Neural Cell Therapy Candidate | SAN FRANCISCO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the nervous system, today announced that the California Institute for Re... |
| 12.03.2024 | Neurona Therapeutics to Present at Stifel 2024 Virtual CNS Days | SAN FRANCISCO, March 12, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders, today announced that Cory R. Nichol... |
| 12.03.2024 | Neurona Therapeutics to Present at Stifel 2024 Virtual CNS Days | - |
| 07.03.2024 | Neurona Therapeutics Announces Presentation of Updated Clinical Data at the Upcoming American Academy of Neurology (AAN) Annual Meeting from Lead Cell Therapy Candidate, NRTX-1001 | - |
| 09.02.2024 | Neurona Therapeutics Raises $120M in Funding | Neurona Therapeutics, a San Francisco, CA-based clinical-stage biotherapeutics company, raised $120M in funding. The round was led by Viking Global Investors and Cormorant Asset Management with participation from new and existing investors,... |
| 08.02.2024 | Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Candidates for Chronic Neurological Disorders | San Francisco, CA, February 8, 2024 – Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders, today announced the successful completion of a ... |
| 08.02.2024 | Neurona Therapeutics Lands $120M | SAN FRANCISCO, CA, Neurona Therapeutics today announced the successful completion of a $120 million financing. >> Click here for more funding data on Neurona Therapeutics >> To export Neurona Therapeutics funding data to PDF... |
| 08.02.2024 | Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Candidates for Chronic Neurological Disorders | - |
Show more